452 related articles for article (PubMed ID: 7690782)
1. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
[TBL] [Abstract][Full Text] [Related]
2. Significance of specific antibody assay for genotyping of hepatitis C virus.
Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
4. [Second generation hepatitis-C virus test and polymerase chain reaction in anti-C 100 negative patients with chronic non-A, non-B hepatitis].
Zala G; Havelka J; Wicki AN; Joller-Jemelka HI; Meier B; Schmid M; Bühler H
Schweiz Med Wochenschr; 1992 Mar; 122(11):363-8. PubMed ID: 1313601
[TBL] [Abstract][Full Text] [Related]
5. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
[TBL] [Abstract][Full Text] [Related]
6. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
7. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
Sugiyasu T
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.
Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E
Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and clinical implications of the different genotypes of hepatitis C virus.
Bukh J; Miller RH
Hepatology; 1994 Jul; 20(1 Pt 1):256-9. PubMed ID: 7517384
[No Abstract] [Full Text] [Related]
12. [Antibodies against hepatitis C virus. Experience with a second generation test].
Garassini MA; Ortega F; Alvarado M; Valdés A; Díaz F; Dugarte I; Serrano L
G E N; 1991; 45(3):183-9. PubMed ID: 1726913
[TBL] [Abstract][Full Text] [Related]
13. [Interpretation of Ortho HCV Ab ELISA test results by chiron HCV recombinant immunoblot assay].
Yahagi N; Kitsugi K
Rinsho Byori; 1991 Jan; 39(1):26-33. PubMed ID: 1848912
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
[TBL] [Abstract][Full Text] [Related]
16. [Virological studies on the usefulness of anti-HCV ELISA assay using recombinant N-14 fusion protein in various liver diseases].
Imamura S
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):138-47. PubMed ID: 7686126
[TBL] [Abstract][Full Text] [Related]
17. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease.
Chemello L; Cavalletto D; Pontisso P; Bortolotti F; Donada C; Donadon V; Frezza M; Casarin P; Alberti A
Hepatology; 1993 Feb; 17(2):179-82. PubMed ID: 8381380
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia.
Sinico RA; Ribero ML; Fornasieri A; Renoldi P; Zhou J; Fasola M; Portera G; Arrigo G; Gibelli A; D'Amico G
QJM; 1995 Nov; 88(11):805-10. PubMed ID: 8542265
[TBL] [Abstract][Full Text] [Related]
19. Virological features of hepatitis C virus infection in patients with liver diseases in the inshore area of the Yangtze River.
Yao DF; Horie C; Horie T; Shimizu I; Meng XY; Ito S
Tokushima J Exp Med; 1994 Jun; 41(1-2):49-56. PubMed ID: 7524191
[TBL] [Abstract][Full Text] [Related]
20. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
